SPRINKLR INC-A (CXM)

US85208T1079 - Common Stock

11.98  +0.15 (+1.27%)

After market: 11.95 -0.03 (-0.25%)

Fundamental Rating

5

Overall CXM gets a fundamental rating of 5 out of 10. We evaluated CXM against 276 industry peers in the Software industry. CXM has only an average score on both its financial health and profitability. While showing a medium growth rate, CXM is valued expensive at the moment.



5

1. Profitability

1.1 Basic Checks

In the past year CXM was profitable.
In the past year CXM had a positive cash flow from operations.
CXM had negative earnings in 4 of the past 5 years.
Of the past 5 years CXM 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 4.20%, CXM is in the better half of the industry, outperforming 78.83% of the companies in the same industry.
The Return On Equity of CXM (7.56%) is better than 79.56% of its industry peers.
With a decent Return On Invested Capital value of 4.03%, CXM is doing good in the industry, outperforming 77.37% of the companies in the same industry.
Industry RankSector Rank
ROA 4.2%
ROE 7.56%
ROIC 4.03%
ROA(3y)-4.45%
ROA(5y)-6.93%
ROE(3y)-8.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CXM has a better Profit Margin (7.02%) than 78.47% of its industry peers.
Looking at the Operating Margin, with a value of 4.64%, CXM is in the better half of the industry, outperforming 74.45% of the companies in the same industry.
With a decent Gross Margin value of 75.49%, CXM is doing good in the industry, outperforming 69.71% of the companies in the same industry.
CXM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.64%
PM (TTM) 7.02%
GM 75.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.33%
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CXM is destroying value.
Compared to 1 year ago, CXM has more shares outstanding
CXM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CXM has an Altman-Z score of 4.24. This indicates that CXM is financially healthy and has little risk of bankruptcy at the moment.
CXM's Altman-Z score of 4.24 is fine compared to the rest of the industry. CXM outperforms 64.60% of its industry peers.
CXM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.24
ROIC/WACC0.41
WACC9.95%

2.3 Liquidity

CXM has a Current Ratio of 1.97. This is a normal value and indicates that CXM is financially healthy and should not expect problems in meeting its short term obligations.
CXM has a Current ratio (1.97) which is comparable to the rest of the industry.
A Quick Ratio of 1.97 indicates that CXM should not have too much problems paying its short term obligations.
CXM's Quick ratio of 1.97 is in line compared to the rest of the industry. CXM outperforms 59.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.97

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 186.52% over the past year.
CXM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.48%.
CXM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.70% yearly.
EPS 1Y (TTM)186.52%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q116.67%
Revenue 1Y (TTM)18.48%
Revenue growth 3Y23.7%
Revenue growth 5YN/A
Revenue growth Q2Q17.49%

3.2 Future

CXM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.05% yearly.
CXM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.75% yearly.
EPS Next Y-1.24%
EPS Next 2Y11.46%
EPS Next 3Y16.05%
EPS Next 5YN/A
Revenue Next Year10.82%
Revenue Next 2Y11.12%
Revenue Next 3Y11.75%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

CXM is valuated quite expensively with a Price/Earnings ratio of 30.72.
Compared to the rest of the industry, the Price/Earnings ratio of CXM indicates a somewhat cheap valuation: CXM is cheaper than 74.82% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 25.25. CXM is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 31.10 indicates a quite expensive valuation of CXM.
CXM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CXM is cheaper than 70.07% of the companies in the same industry.
CXM's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 21.67.
Industry RankSector Rank
PE 30.72
Fwd PE 31.1

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CXM indicates a somewhat cheap valuation: CXM is cheaper than 72.26% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CXM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 64
EV/EBITDA 42.66

4.3 Compensation for Growth

A more expensive valuation may be justified as CXM's earnings are expected to grow with 16.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.46%
EPS Next 3Y16.05%

0

5. Dividend

5.1 Amount

No dividends for CXM!.
Industry RankSector Rank
Dividend Yield N/A

SPRINKLR INC-A

NYSE:CXM (4/24/2024, 7:04:00 PM)

After market: 11.95 -0.03 (-0.25%)

11.98

+0.15 (+1.27%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.27B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 30.72
Fwd PE 31.1
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.2%
ROE 7.56%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.64%
PM (TTM) 7.02%
GM 75.49%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.97
Quick Ratio 1.97
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)186.52%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-1.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)18.48%
Revenue growth 3Y23.7%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y